These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2178384)
1. Effects of captopril versus milrinone therapy in modulating the adrenergic nervous system response to exercise in congestive heart failure. Corbalán R; Jalil J; Chamorro G; Casanegra P; Valenzuela P Am J Cardiol; 1990 Mar; 65(9):644-9. PubMed ID: 2178384 [TBL] [Abstract][Full Text] [Related]
2. Milrinone for long-term therapy of severe heart failure: clinical experience with special reference to maximal exercise tolerance. LeJemtel TH; Gumbardo D; Chadwick B; Rutman HI; Sonnenblick EH Circulation; 1986 Mar; 73(3 Pt 2):III213-8. PubMed ID: 3510777 [TBL] [Abstract][Full Text] [Related]
3. Exercise responses before and after long-term treatment with oral milrinone in patients with severe heart failure. Ribeiro JP; White HD; Arnold JM; Hartley LH; Colucci WS Am J Med; 1986 Nov; 81(5):759-64. PubMed ID: 3535490 [TBL] [Abstract][Full Text] [Related]
4. Immediate effects of milrinone on metabolic and sympathetic responses to exercise in severe congestive heart failure. White HD; Ribeiro JP; Hartley LH; Colucci WS Am J Cardiol; 1985 Jul; 56(1):93-8. PubMed ID: 4014048 [TBL] [Abstract][Full Text] [Related]
5. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise. Bayliss J; Canepa-Anson R; Norell MS; Poole-Wilson P; Sutton G Br Heart J; 1986 Mar; 55(3):265-73. PubMed ID: 3513808 [TBL] [Abstract][Full Text] [Related]
6. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril). Kluger J; Cody RJ; Laragh JH Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087 [TBL] [Abstract][Full Text] [Related]
7. [Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine]. Drexler H; Faude F; Winterer H; Wollschläger H; Freudenberg N; Just H Z Kardiol; 1987 Aug; 76(8):507-13. PubMed ID: 3314215 [TBL] [Abstract][Full Text] [Related]
8. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. DiBianco R; Shabetai R; Kostuk W; Moran J; Schlant RC; Wright R N Engl J Med; 1989 Mar; 320(11):677-83. PubMed ID: 2646536 [TBL] [Abstract][Full Text] [Related]
9. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. Packer M; Carver JR; Rodeheffer RJ; Ivanhoe RJ; DiBianco R; Zeldis SM; Hendrix GH; Bommer WJ; Elkayam U; Kukin ML N Engl J Med; 1991 Nov; 325(21):1468-75. PubMed ID: 1944425 [TBL] [Abstract][Full Text] [Related]
10. Milrinone in heart failure. Effects on exercise haemodynamics during short term treatment. Timmis AD; Smyth P; Jewitt DE Br Heart J; 1985 Jul; 54(1):42-7. PubMed ID: 4015915 [TBL] [Abstract][Full Text] [Related]
11. Milrinone. A preliminary review of its pharmacological properties and therapeutic use. Young RA; Ward A Drugs; 1988 Aug; 36(2):158-92. PubMed ID: 3053125 [TBL] [Abstract][Full Text] [Related]
12. Systemic and regional hemodynamic effects of captopril and milrinone administered alone and concomitantly in patients with heart failure. LeJemtel TH; Maskin CS; Mancini D; Sinoway L; Feld H; Chadwick B Circulation; 1985 Aug; 72(2):364-9. PubMed ID: 3891133 [TBL] [Abstract][Full Text] [Related]
13. Clinical results with oral milrinone in heart failure. DiBianco R Eur Heart J; 1989 Aug; 10 Suppl C():44-52. PubMed ID: 2680497 [TBL] [Abstract][Full Text] [Related]
14. Survival of patients with severe congestive heart failure treated with oral milrinone. Baim DS; Colucci WS; Monrad ES; Smith HS; Wright RF; Lanoue A; Gauthier DF; Ransil BJ; Grossman W; Braunwald E J Am Coll Cardiol; 1986 Mar; 7(3):661-70. PubMed ID: 3950244 [TBL] [Abstract][Full Text] [Related]
15. Long-term treatment of severe chronic heart failure with captopril: a double-blind, randomized, placebo-controlled, long-term study. Bussmann WD; Störger H; Hadler D; Reifart N; Fassbinder W; Jungmann E; Kaltenbach M J Cardiovasc Pharmacol; 1987; 9 Suppl 2():S50-60. PubMed ID: 2441202 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of phosphodiesterase inhibition with milrinone in combination with converting enzyme inhibitors in patients with heart failure. The Milrinone Multicenter Trials Investigators. Colucci WS; Sonnenblick EH; Adams KF; Berk M; Brozena SC; Cowley AJ; Grabicki JM; Kubo SA; LeJemtel T; Littler WA J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):113A-118A. PubMed ID: 8376682 [TBL] [Abstract][Full Text] [Related]
17. Sympathetic activation on effort in patients with chronic heart failure. Long term effects of captopril. Boschetti E; Tantucci C; Cocchieri M; Castellano M; Alunni G; Bruni B; Fortunati F; Grassi V Acta Cardiol; 1988; 43(5):569-82. PubMed ID: 3149103 [TBL] [Abstract][Full Text] [Related]
18. Sympathetic responsiveness and plasma norepinephrine during therapy of chronic congestive heart failure with captopril. Cody RJ; Franklin KW; Kluger J; Laragh JH Am J Med; 1982 May; 72(5):791-7. PubMed ID: 7044120 [TBL] [Abstract][Full Text] [Related]
19. [The effect of hemodynamic changes in 24-hour milrinone infusion on sympathetic activity and the renin-angiotensin-aldosterone system in patients with severe heart failure]. Mager G; Steffen HM; Klocke RK; Wambach G; Kux A; Degenhardt S; Höpp HW; Hilger HH Z Kardiol; 1991 Apr; 80(4):272-8. PubMed ID: 1862668 [TBL] [Abstract][Full Text] [Related]
20. [Response to milrinone treatment in patients with chronic congestive heart failure]. Zeng H; Wen S; Huang D; Liu X; Fang Y Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):246-7, 259. PubMed ID: 12515150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]